Skip to main content

Sandra Mancilla Zamora

Anatomy technician with more than 20 years of experience, responsible for the histology section of the area of Functional Validation and Preclinical Studies (FVPR) and the Drugs Delivery Targeting (DDT) group of the VHIR. I give assistance to the in vitro section and the in vivo section of FVPR, which is part of the ICTS of Nanbiosis providing support services to companies / research groups.

Institutions of which they are part

Research technician
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Vall Hebron Institut de Recerca

Sandra Mancilla Zamora

Institutions of which they are part

Research technician
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Vall Hebron Institut de Recerca

Anatomy technician with more than 20 years of experience, responsible for the histology section of the area of Functional Validation and Preclinical Studies (FVPR) and the Drugs Delivery Targeting (DDT) group of the VHIR. I give assistance to the in vitro section and the in vivo section of FVPR, which is part of the ICTS of Nanbiosis providing support services to companies / research groups.

Degrees:
Stable animal experimentation course. ABC function in 2020
Senior Clinical Analysis Technician in 2005
Higher Techniques in Pathological Anatomy and Cytology in 2001.

Currently Vall d'Hebron University Hospital. VHIR-CIBBIM. FVPR since 01/11/2017
Technician in charge of the histology section of FVPR and the DDT group of the VHIR.
With knowledge in environment and quality management at ISO 9001. Application management, internal positions…
They also carry out research with various projects where I am in charge of the processing of the samples, making blocks, cuts, stains, immune.
I give assistance the in vitro section (cell culture) and molecular biology techniques (western blot, enzymatic activities ...) and the in vivo section helping to prepare treatments, subcutaneous, intravenous cell inoculation, mammary, control of mice’s evolution, weight, tumor size, etc., necropsies and collection of biological samples for further processing.
Responsible for the control of own equipment, maintenance, verification and calibration. Order control and organization of the general laboratory.

Projects

NanoDIRE-CT - Uso de nanobodies para terapia dirigida contra células madre tumorales

IP: Ibane Abasolo Olaortua
Collaborators: Sandra Mancilla Zamora, Zamira Vanessa Diaz Riascos, Fernanda Raquel Da Silva Andrade, Diana Fernandes de Rafael, Simon Schwartz Navarro
Funding agency: Ministerio de Ciencia e Innovación-MICINN
Funding: 322172.61
Reference: RTC2019-006809-1
Duration: 01/09/2020 - 31/12/2023

Ministerio de Ciencia

Desenvolupament de noves nanopartícules funcionals dirigides al nòdul limfàtic per a l'eliminació del reservori latent de VIH

IP: María José Buzón Gómez
Collaborators: Ibane Abasolo Olaortua, Félix Pumarola Segura, Juan Lorente Guerrero, Laura García Latorre, Jordi Temprana Salvador, Joaquin Seras Franzoso, Marc Pellicer Sarasa, David Perea Pérez, Simon Schwartz Navarro, Jordi Navarro Mercadé, Sandra Mancilla Zamora, Zamira Vanessa Diaz Riascos, Judit Grau Exposito, Meritxell Genesca Ferrer, Fernanda Raquel Da Silva Andrade, Diana Fernandes de Rafael
Funding agency: Fundació La Marató de TV3
Funding: 199998.75
Reference: 20180510
Duration: 10/05/2019 - 31/12/2022

Evolvable platform for designing cancer treatment strategies using nanoparticles (EVO-NANO)

IP: Ibane Abasolo Olaortua
Collaborators: Joaquin Seras Franzoso, Simon Schwartz Navarro, Sandra Mancilla Zamora, Zamira Vanessa Diaz Riascos, Belen Garcia Prats
Funding agency: EUROPEAN COMMISSION
Funding: 568847.5
Reference: EVO-NANO_H2020FETOPEN2017
Duration: 01/10/2018 - 31/03/2022

Mejora del tratamiento de las enfermedades de depósito lisosomal mediante vehículos nanométricos optimizados.

IP: Ibane Abasolo Olaortua
Collaborators: Sandra Mancilla Zamora, Zamira Vanessa Diaz Riascos, Fernanda Raquel Da Silva Andrade, Diana Fernandes de Rafael
Funding agency: Instituto de Salud Carlos III
Funding: 116160
Reference: PI18/00871
Duration: 01/01/2019 - 30/06/2022

Related news

The European project, in which Vall d'Hebron participates, will favor personalized diagnosis and innovative therapeutic strategies in patients with the disease.

In total, different projects of six research groups will be promoted, focusing on precision medicine and advanced therapies.

During the last year, the collaboration between Vall d’Hebron and ZeClinics has found three nanobody candidates with potent anticancer properties in zebrafish model.

Related professionals

Xurxo Segura Navarro

Xurxo Segura Navarro

Predoctoral researcher
Research Group of Physical Medicine and Rehabilitation
Read more
Mercedes López González

Mercedes López González

Main researcher
Kidney Physiopathology
Read more
Daniel Carranza Rojo

Daniel Carranza Rojo

Senior researcher
Pediatric Neurology
Read more
Rosa Burgos Peláez

Rosa Burgos Peláez

Main researcher
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.